166 related articles for article (PubMed ID: 21168919)
1. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
[TBL] [Abstract][Full Text] [Related]
2. A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression.
Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
J Affect Disord; 2011 Jan; 128(1-2):56-63. PubMed ID: 20643483
[TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
4. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
[TBL] [Abstract][Full Text] [Related]
5. Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
Serretti A; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Pae CU
Psychiatry Res; 2011 Aug; 189(1):26-32. PubMed ID: 21396719
[TBL] [Abstract][Full Text] [Related]
6. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
Okumura T; Kishi T; Okochi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Tsunoka T; Inada T; Ozaki N; Iwata N
Neuropsychobiology; 2010; 61(2):57-63. PubMed ID: 20016223
[TBL] [Abstract][Full Text] [Related]
7. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.
Baune BT; Dannlowski U; Domschke K; Janssen DG; Jordan MA; Ohrmann P; Bauer J; Biros E; Arolt V; Kugel H; Baxter AG; Suslow T
Biol Psychiatry; 2010 Mar; 67(6):543-9. PubMed ID: 20044070
[TBL] [Abstract][Full Text] [Related]
8. Association of catechol-O-methyltransferase variants with duloxetine response in major depressive disorder.
Houston JP; Kohler J; Ostbye KM; Heinloth A; Perlis RH
Psychiatry Res; 2011 Oct; 189(3):475-7. PubMed ID: 21788083
[TBL] [Abstract][Full Text] [Related]
9. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
[TBL] [Abstract][Full Text] [Related]
10. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphism in the drug transporter gene ABCB1 in treatment-resistant depression: clinical practice.
Rosenhagen MC; Uhr M
J Clin Psychopharmacol; 2010 Apr; 30(2):209-11. PubMed ID: 20520302
[No Abstract] [Full Text] [Related]
12. Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
Serretti A; Chiesa A; Crisafulli C; Massat I; Linotte S; Calati R; Kasper S; Bailer U; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
Neuropsychobiology; 2012; 65(2):70-5. PubMed ID: 22222462
[TBL] [Abstract][Full Text] [Related]
13. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
Chi MH; Chang HH; Lee SY; Lee IH; Gean PW; Yang YK; Lu RB; Chen PS
J Affect Disord; 2010 Nov; 126(3):430-5. PubMed ID: 20674983
[TBL] [Abstract][Full Text] [Related]
14. 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Noro M; Antonijevic I; Forray C; Kasper S; Kocabas NA; Lecrubier Y; Linotte S; Mendlewicz J; Montgomery S; Snyder L; Souery D; Verbanck P; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):228-31. PubMed ID: 20453658
[TBL] [Abstract][Full Text] [Related]
15. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients.
Häfner S; Baghai TC; Eser D; Schüle C; Rupprecht R; Bondy B; Bedarida G; von Schacky C
J Psychiatr Res; 2008 Jan; 42(2):163-5. PubMed ID: 17391703
[No Abstract] [Full Text] [Related]
17. Neuropeptide Y (NPY) gene: Impact on emotional processing and treatment response in anxious depression.
Domschke K; Dannlowski U; Hohoff C; Ohrmann P; Bauer J; Kugel H; Zwanzger P; Heindel W; Deckert J; Arolt V; Suslow T; Baune BT
Eur Neuropsychopharmacol; 2010 May; 20(5):301-9. PubMed ID: 19854625
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.
Tzvetkov MV; Brockmöller J; Roots I; Kirchheiner J
Pharmacogenet Genomics; 2008 Jun; 18(6):495-506. PubMed ID: 18496129
[TBL] [Abstract][Full Text] [Related]
20. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study.
Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM
CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
